Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

17.51 +0.55 (+3.24%)
Streaming Delayed Price Updated: 3:45 PM EDT, Jul 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Simulations Plus, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities
From Simulations Plus, Inc.
Via Business Wire
7 Stocks Under $50 to Buy (and Never Sell)
Although you usually get what you pay for, these best affordable stocks to invest in punch above their weight class. 
Via InvestorPlace
Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes
From Simulations Plus, Inc.
Via Business Wire
Preview: Simulations Plus's Earnings
Via Benzinga
Earnings Preview For Simulations Plus
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
Via Benzinga
Roblox And 3 Other Stocks Insiders Are Selling
The Nasdaq Composite closed sharply higher on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results
From Simulations Plus, Inc.
Via Business Wire
MIDD+ 2023 Panelists Discuss How to Increase Gender Equity for Women in Science
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at Sidoti March Small-Cap Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds
From Simulations Plus, Inc.
Via Business Wire
Lixoft Adds New Data Formatting and Reporting Modules to MonolixSuite™ in Version 2023R1
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at Oppenheimer 33rd Annual Healthcare Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement
From Simulations Plus, Inc.
Via Business Wire
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 63 companies set new 52-week lows. 
Via Benzinga
Constellation Brands, Walgreens, RPM International And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Simulations Plus Reports First Quarter Fiscal 2023 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Earnings Scheduled For January 4, 2023
Companies Reporting Before The Bell • UniFirst (NYSE:UNF) is likely to report quarterly earnings at $1.94 per share on revenue of $527.51 million. 
Via Benzinga
UniFirst, Progress Software And 3 Stocks To Watch Heading Into Wednesday
With US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Investor Fear Increases Slightly As US Stocks Settle Lower On First Trading Session Of 2023
The CNN Money Fear and Greed index showed a slight increase in the fear level among US investors. US stocks closed lower on the first trading session of 2023, giving up gains recorded earlier during... 
Via Benzinga
Simulations Plus Sets Date for First Quarter Fiscal Year 2023 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus and the University of Bath Awarded New FDA Grant
From Simulations Plus, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.